Synthetic Biologics to Report 2020 Year End Operational Highlights and Financial Results on March 4, 2021
- Thursday, February 25, 2021, 7:05
- Finance
- Add a comment
ROCKVILLE, Md., Feb. 25, 2021 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, intends to report…
About the Author
adminasapcorp has written 39694 stories on this site.